Neuroaxial Prophylaxis for CABG

Coronary Artery Occlusion Clinical Trial

Official title: Consequences of Using Thoracic Epidural Analgesia for Coronary Artery Bypass Grafting

Status Enrolling by invitation

Clinical Trial Summary

Investigators plan to study the effect of thoracic epidural analgesia on postoperative parameters (complication rate, duration of hospitalization, mortality, etc.) of coronary artery bypass grafting.

Clinical Trial Description

Investigators plan to conduct a comparative analysis of early postoperative complications of coronary artery bypass grafting with and without cardiopulmonary bypass in patients with independent risk factors for the development of postoperative complications (advanced age, diabetes mellitus, chronic kidney disease, obesity, chronic obstructive pulmonary disease) with various types of anesthesiology benefits (general anesthesia and thoracic epidural analgesia versus general anesthesia and opioids). Investigators predict a decrease in the risk of developing cardiac, respiratory, infectious and renal complications, a reduction in the duration of intensive care, inpatient treatment and mortality. ;

Related Conditions & MeSH terms

• Coronary Artery Occlusion
• Coronary Occlusion

• NCT number: NCT04244435
• Study type: Interventional
• Source: Volgograd State Medical University
• Status: Enrolling by invitation
• Phase: Early Phase 1
• Start date: February 1, 2020
• Completion date: January 31, 2022